Seeing Is Believing
Currently, out of the existing stock ratings of Stephanie Davis - 109 which are a Buy (63.74%), 52 which are a Hold (30.41%), 10 which are a Sell (5.85%)
Analyst Stephanie Davis works at LEERINK and is covering Healthcare, Technology sectors with 322 price targets and ratings displayed on 24 stocks. Previously, Stephanie Davis worked at CITI, JPMORGAN.
Stephanie Davis's average stock forecast success ratio is 68.24% with an average time for price targets to be met of 153.88 days.
Most recent stock forecast was given on TDOC, Teladoc Health at 23-Feb-2023.
Analyst best performing recommendations are on LVGO.
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
17
$7.76 (83.98%)
18
2 months 5 days ago
4/10 (40%)
$8.53 (100.71%)
81
Buy
18
2 months 5 days ago
1/12 (8.33%)
$3.87 (27.39%)
69
Buy
17
$7.76 (83.98%)
17
2 months 8 days ago
4/12 (33.33%)
$6.53 (62.37%)
86
Buy
17
$7.76 (83.98%)
15
2 months 8 days ago
4/9 (44.44%)
$6.53 (62.37%)
86
Hold
14
$4.76 (51.52%)
14
5 months 7 days ago
7/9 (77.78%)
$0.81 (6.14%)
38
What Year was the first public recommendation made by Stephanie Davis?